Basophil Histamine Release Decreases during Omalizumab Therapy in Allergic Asthmatics

Publisher： Karger

E-ISSN： 1423-0097|146|1|66-70

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.146, Iss.1, 2007-12, pp. : 66-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-IgE Therapy with Omalizumab Decreases Endothelin-1 in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma

By  

Respiration, Vol. 80, Iss. 6, 2010-06 ,pp. : 534-542

Karger

Access to resources Recommend Favorite

Immunological and Clinical Changes in Allergic Asthmatics following Treatment with Omalizumab

By  

International Archives of Allergy and Immunology, Vol. 131, Iss. 1, 2003-05 ,pp. : 46-52

Karger

Access to resources Recommend Favorite

RANTES in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma during Omalizumab Therapy

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 1, 2010-07 ,pp. : 25-32

Karger

Access to resources Recommend Favorite

Allergy to Formaldehyde: Basophil Histamine-Release Test Is Useful for Diagnosis

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 1, 2014-05 ,pp. : 27-29

Karger

Access to resources Recommend Favorite

A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy

By  

ALLERGY, Vol. 73, Iss. 1, 2018-01 ,pp. : 137-144

John Wiley & Sons Inc

Access to resources Recommend Favorite